Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) EBT: 2011-2025

Historic EBT for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to -$13.7 million.

  • Aytu Biopharma's EBT rose 31.17% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.3 million, marking a year-over-year decrease of 843.71%. This contributed to the annual value of -$13.7 million for FY2025, which is 32.44% down from last year.
  • Aytu Biopharma's EBT amounted to -$13.7 million in FY2025, which was down 32.44% from -$10.4 million recorded in FY2024.
  • Aytu Biopharma's EBT's 5-year high stood at -$10.4 million during FY2024, with a 5-year trough of -$108.9 million in FY2022.
  • Over the past 3 years, Aytu Biopharma's median EBT value was -$13.7 million (recorded in 2025), while the average stood at -$13.7 million.
  • Per our database at Business Quant, Aytu Biopharma's EBT crashed by 326.03% in 2021 and then soared by 84.34% in 2023.
  • Over the past 5 years, Aytu Biopharma's EBT (Yearly) stood at -$58.0 million in 2021, then crashed by 87.64% to -$108.9 million in 2022, then spiked by 84.34% to -$17.1 million in 2023, then spiked by 39.14% to -$10.4 million in 2024, then tumbled by 32.44% to -$13.7 million in 2025.